Kyrgyzstan vs Senegal: Incidence of tuberculosis
Incidence of tuberculosis over time
- Kyrgyzstan
- Senegal
How they compare
Senegal currently reports 132 per 100,000 people against 128 per 100,000 people in Kyrgyzstan, a difference of 4 per 100,000 people.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 54th and Senegal ranks 52nd of 208 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | Kyrgyzstan | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 268 per 100,000 people | 181.7 per 100,000 people | 86.3 per 100,000 people | Kyrgyzstan |
| 2010s | 172.4 per 100,000 people | 164.7 per 100,000 people | 7.7 per 100,000 people | Kyrgyzstan |
| 2020s | 131 per 100,000 people | 134.8 per 100,000 people | 3.8 per 100,000 people | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Kyrgyzstan or Senegal?
- Senegal, at 132 per 100,000 people against 128 per 100,000 people in Kyrgyzstan as of 2024.
- What is the difference in incidence of tuberculosis between Kyrgyzstan and Senegal?
- 4 per 100,000 people, with Senegal ahead.
- How many years of comparable data are there for Kyrgyzstan and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do Kyrgyzstan and Senegal rank globally for incidence of tuberculosis?
- Kyrgyzstan ranks 54th and Senegal ranks 52nd of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.